Malin Corporation plc is an Irish incorporated public limited company whose head office is in Dublin, Ireland. The registered number for Malin Corporation plc is 554442.
Malin invests in and supports highly innovative life sciences companies developing exceptional science and technology to deliver transformative outcomes for patients and create significant value for shareholders.
Our purpose is to create shareholder value through the application of long-term capital and strategic support to its investee companies to enable them to reach their value potential.
Malin is headquartered in Ireland and listed on Euronext Dublin.
The Board of Malin Corporation plc is comprised of four Directors, of whom one has executive functions.
The Board has established an Audit Committee, Remuneration Committee and a Nominations and Governance Committee with formally delegated duties and responsibilities as described below:
The Audit Committee shall be made up of at least three Non-Executive Directors a majority of whom shall be Independent Non-Executive Directors and at least one of whom shall have recent and relevant financial experience. The members of the Audit Committee are:
- Liam Daniel (Chairman), Independent Non-Executive Director
- Rudy Mareel, Lead Independent Non-Executive Director
- Ian Curley, Chairman of Malin
All of the members of the Audit Committee have recent and relevant financial experience. The Audit Committee will meet at least four times a year and will be responsible for ensuring that the financial performance of the Company is properly monitored and reported. The committee will also meet with the external auditor to review findings of the audit. It will meet with the auditors at least once a year without any members of management being present and will also be responsible for considering and making recommendations regarding the identity and remuneration of such auditors.
The Remuneration Committee shall be made up of at least two Non-Executive Directors at least one of whom shall be an Independent Non-Executive Director. The members of the Remuneration Committee are:
- Jean Michel Cosséry (Chairman), Non-Executive Director
- Ian Curley, Chairman of Malin
The Remuneration Committee will meet at least once a year and will consider and recommend to the Board the framework for the remuneration of the chief executive officer, the chairman, company secretary, chief financial officer and such other officers as it is designated to consider and, within the terms of the agreed policy will, consider and recommend to the Board the total individual remuneration package of each executive Director including bonuses and incentive payments. It will review the design of all incentive plans for approval by the Board and (if required) shareholders and, for each such plan, recommend whether awards are made and, if so, the overall amount of such awards, the individual awards to executive Directors and the performance targets to be used. No Director will be involved in decisions concerning his/her own remuneration.
Nominations and Governance Committee
The Nominations Committee shall be made up of at least two Non-Executive Directors at least one of whom shall be an Independent Non-Executive Director. The members of the Nominations Committee are:
- Ian Curley (Chairman), Chairman of Malin
- Jean Michel Cosséry, Independent Non-Executive Director
The Nominations Committee will meet at least once a year and will consider the selection and re-appointment of Directors. It will identify and nominate candidates for all Board vacancies and will regularly review the structure, size and composition (including the skills, knowledge and experience) of the Board and make recommendations to the Board with regard to any changes.
Information for U.S. Shareholders
We have concluded that Malin Corporation plc is a Passive Foreign Investment Company (“PFIC”) for U.S. federal income tax purposes for the year ended December 31, 2018. The below Information Statement has been provided to allow you to complete a Form 8621 and make a Qualifying Electing Fund (“QEF”) election, should you choose to do so.
As a company’s PFIC status for a given tax year will not be determinable until the close of that year, no determination can be made at this point in time with regard to PFIC status in any future year.
This information does not constitute tax advice and we encourage you to consult with your tax advisor with respect to the treatment of your shareholdings for U.S. tax purposes and to provide them with the attached Information Statement.
Euronext Growth Market Adviser and Joint Corporate Broker
49 Dawson Street
Joint Corporate Broker
25 Ropemaker Street
North Wall Quay
Reporting Accountants and Auditors
1 Stokes Place
St Stephen's Green
Computershare Investor Services
3100 Lake Drive
Citywest Business Campus
Malin is subject to the Irish Takeover Panel Act 1997, Takeover Rules, 2013 (“Takeover Rules”). Read more